I believe that there is something we all need to remember, it doesn't matter how long the Journal is taking, the company is doing all the other things it must to gain regulatory approval and that's really is what's most important.
There are people who'll tell you they'll never be published, or if they are it will be in one of the lesser Journal's where money can do the job. I'm still of the belief that we'll be published in a top tier Journal, but I can't say which one. I'm of the belief that the trial is so complex that it warrants a presentation that's not size limited, which favors Annuls of Oncology, but if it's NEJM or Lancet with limited word counts, it will still have the credibility we all want to see. I gather that the whole story could be made with more than a single presentation, and that too may be a possibility.
To me, what's possibly most important is what happens after the Journal is out. Do we get coverage in the national or worldwide media? If we do, no telling how high the share price moves as investors who've never heard of NWBO learn about it and want in.